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A mutant polyoma virus (lT340), which replicates in F9 embryonal carcinoma (EC) cells 
and contains 2500 base pairs (bp) of additional DNA located in the early noncoding region of 
the genome, was analyzed to determine the DNA origin of the mutant insertion. Two frag- 
ments, representing repeated units of the 2500-bp insert, were isolated from TT340, labeled, 
and hybridized to the parental wild-type viral DNA. A BglI 500-bp unit, of which there are 
approximately live copies within the 2500-bp insert, contains sequences homologous to 
regions on the early and late side of the viral origin of replication. A HpaII 400-bp repeated 
fragment shows homology to sequences on the early side with little hybridization to the late 
side. Removal of the 2500-bp insert results in the loss of infectivity on F9 EC cells but not 
on 3T6 or mouse embryo fibroblasts. Insertion of the BglI SOO-bp repeat element into wild- 
type DNA at the BglI site allows replication of the constructed virus in F9 cells. The mutant 
virions were tumorigenic in newborn Syrian hamsters and the morphology of the virus was 
that of wild-type as assayed by electron microscopy. Q 1987 Academic press, IIIC. 
INTRODUCTION 
The stem cell of the murine teratocarcinoma, embryonal carcinoma (EC), re- 
stricts the expression of the Simian virus 40 and polyoma. However, the differen- 
tiated cells obtained from the embryonal carcinoma will express polyoma permis- 
sively and SV40 nonpermissively (Swartzendruber and Lehman, 1975; Boccara 
and Kelly, 1978). Recently, a number of mutant polyoma viruses have been iso- 
lated which replicate in certain embryonal carcinoma cell lines (Fujimura et al., 
1981; Katinka et al., 1981; Katinka et al., 1980; Sekikawa and Levine, 1981; Vas- 
seur et al., 1982). Analysis of these mutants may be useful in defining the block to 
wild-type polyoma virus expression in the stem cell. The majority of these mu- 
tants had alterations near and to the late side of the origin of viral DNA replica- 
tion in a noncoding region which contains the enhancer region of polyoma (Her- 
borne1 et al., 1984). These mutants include single base pair changes, small dele- 
tions and duplications and sequence duplications that encompass single-point 
mutations. 
Another mutant polyoma (TT340) was isolated that had a large insertion (2500 
bp) on the early side of the genome in a noncoding region between the two Hue11 
sites at positions 84 and 95 (Bevor and Lehman, 1983). This mutant was of in- 
terest due to the large size of the DNA (7700 bp) and the fact that the change was 
in the early noncoding side of the genome. 
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In this paper TT340 viral DNA was analyzed to determine the DNA origin of 
the 2500-bp insertion and whether this insertion is necessary for virus expression 
and replication in F9 EC cells. In addition, tumorigenicity and morphology of 
TT340 virus were examined and compared to the parental wild-type virus. 
MATERIALS AND METHODS 
The cell lines utilized in this study were F9 EC carcinoma obtained from Dr. 
E. E. Moore from a subline line originated by Bemstine et al. (1973), 3T6 cells 
from American Type Tissue Culture, and mouse embryo fibroblasts (MEF) estab- 
lished from 15day-old Swiss-Webster mouse embryos (Defendi and Lehman, 
1965). These cells were maintained in Eagle’s minimal essential medium (MEM) 
(Grand Island Biological Co., Grand Island, NY), supplemented with 2 x amino 
acids, vitamins, and antibiotics (100 I.&ml penicillin and 50 pg/ml streptomycin). 
All cells were grown in 5% fetal calf serum (Microbiological Associates) and pas- 
saged twice weekly with 0.25% trypsin in Versene and maintained at 37°C in 5% 
co*. 
The wild-type (wt) polyoma virus used in these studies was the Toronto large 
plaque (TOR) strain, obtained from Dr. I. Macpherson, which was plaque-puri- 
fied and titered (Defendi and Lehman, 1965). 
The mutant polyoma TT340 has been previously described (Trevor and 
Lehman, 1983) and was harvested from 3T6 or MEF-infected cells. Cl14 was con- 
structed as previously described (Trevor and Lehman, 1983) and consists of 
TT340 inserted into the BamHI site of pBR322. PY6 which consists of wt PY 
DNA (A, strain) inserted into the BumHI site of pBR322 was kindly provided by 
Dr. L. P. Villarreal. Cells and virus were assayed and found negative for myco- 
plasma. Transfections were performed by the calcium phosphate precipitation 
technique of Graham and Van der Eb (1973). 
Anti-polyoma tumor (T) antigen serum was obtained by injecting PYB4 cells 
into the peritoneal cavity of brown Norwegian rats and harvesting the ascites 
fluid (Silver et al., 1978). Anti-polyoma viral capsid serum was produced by in- 
jection of purified virus into rabbits. Cells were stained by the indirect immuno- 
fluorescent method as previously described (Lehman and Defendi, 1970). The 
fluorescent-labeled anti-rat or rabbit antibody was obtained from Antibodies, Inc. 
(Davis, CA). Whole cell DNA was isolated as previously described (Friedrich and 
Lehman, 1981) and viral DNA was harvested by the Hirt procedure (1967). Isola- 
tion of PY6 and Cl14 plasmids was performed by the methods of Kohn ef al., 
1979. 
The restriction endonucleases were purchased from Bethesda Research Labo- 
ratories (Rockville, MD) or Worthington Biochemical Co. (Freehold, NJ). Two to 
four units of enzyme per microgram of DNA in the manufacturer’s buffer were 
used. Reactions were incubated at 37°C for 3.5 hr, terminated by the addition of 
0.5% SDS, 10 n&f EDTA, 0.1% bromphenol blue, and 3% glycerol, and immedi- 
ately placed onto an agarose gel for electrophoretic separation. DNA was isolated 
from agarose gels by one of the following methods: (1) low melting point agarose 
by the method of Weislander (1979), (2) electroelution as described by Maniatas 
et al. (1982), and (3) electroelution onto DE81 paper as described by Dretzen et 
al. (1981). For DNA analysis from gels, the DNA was transferred to DBM or 
nitrocellulose paper by the method of Southern (1975). The DNA was assayed by 
32P-labeled DNA probes prepared by the procedure of Rigby et al., (1977). End 
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labeling of DNA was performed by digestion of DNA followed by labeling with 
the Klenow fragment of Escherichia coli DNA polymerase (Maniatas et al., 
1982). 
Ligation of TT340-Derived SOO-bp Length to wt Polyoma 
Toronto large plaque DNA was isolated from infected MEF cells by the Hirt 
procedure (1967) and digested by BgEI endonuclease. The Cl14 DNA was digested 
by Bg& and separated on 1% agarose. The 500-bp band was isolated by electro- 
elution onto DE81 paper and suspended in double distilled water at a concentra- 
tion of 0.810 l&l. Various numbers of the 500-bp fragments were ligated to BgZI 
linearized wt PY DNA as described by Dugaicyzyk et al. (1975). 
Tumorigenicity 
Newborn (~24 hr) LSH Syrian Hamsters were inoculated with 0.1 ml of wild- 
type Toronto strain polyoma, TT340 virus, and Cl14 DNA subcutaneously into 
the suprascapular region. The virus was inoculated at approximately 104 plaque- 
forming units/O.1 ml. The animals were examined once a week until tumors ap- 
peared and were autopsied when the tumors reached a size of 2-3 cm in diam- 
eter. The tissues were placed in Tellyesniczky’s fixative and the tissue sections 
were stained with hematoxylin and eosin. Certain tumors were excised and 
placed into tissue culture (Defendi and Lehman, 1966). 
Electron Microscopy 
The virus suspensions were examined by placing a suspension on a colloidion- 
coated grid and allowed to stand for 15 min in a humidified chamber. The grid was 
washed with 3 drops of phosphotungstic acid (20/o, pH 6-8), and then a thin layer 
of phosphotungstic acid was left for 5 min and dryed with filter paper. The grids 
were examined and photographed with a Phillips 201 transmission microscope. 
Between 15 and 20 particles were measured. 
RESULTS 
Viral Origin of Insert 
In initial studies to determine whether the 2500-bp TT340 mutant insert was 
derived from cellular or viral sequences, mouse cellular DNA was probed with 
the Cl14 plasmid which contains the entire mutant viral genome inserted into 
pBR322. No homology to cellular sequences was observed (data not shown), sug- 
gesting that the insert was of viral DNA origin. Restriction enzyme analysis of 
TT340 DNA indicated that the 2500 bp had been inserted on the early side of the 
TOR strain polyoma genome. HueII, as well as Bgfl, digestion resulted in the 
appearance of approximately five 500-bp fragments which accounted for the 
2500-bp insertion (Trevor and Lehman, 1983). Hue11 restricts polyoma at nucleo- 
tide positions 84 and 95 in the early noncoding regions, while BglI restricts at 
position 87 between the two HaeII sites (Tooze, 1980). HpaII digestion of TT340 
DNA gave 400- and lOO-bp repeated fragments, which most likely derive from the 
500-bp repeats, as well as two fragments migrating at approximately 500 bp and 
200 bp (data not shown). The later two fragments may be rearranged flanking 
sequences which are not repeated. 
To analyze the viral DNA origin of the 500-bp repeats comprising the 2500-bp 
insertion, TT340 DNA was digested with Bg/I, generating the complete 500-bp 
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unit, or with HpaII, generating 400- and lOO-bp fragments of the unit. The 500- 
and 400-bp fragments were isolated, nick translated, and used to probe HpaII 
digested wild-type TOR DNA. As shown in Fig. 1, hybridization of TOR DNA to 
32P-labeled Cl14 plasmid DNA detects several of the fragments expected from 
&a11 digestion of wild-type polyoma DNA (Tooze, 1980). Smaller fragments 
were not seen and most likely were run off the gel during electrophoresis. After 
hybridization of the 32P-labeled BglI 500-bp fragment, strong signals were ob- 
served for the HpaII-3 and HpuII-5 fragments (Fig. 1). The other fainter bands 
were probably due to remaining counts on the filter which were insufficiently 
washed off prior to addition of the probe. A similar result was obtained by uti- 
lizing a probe of the Hue11 SOO-bp fragments derived from TT340 DNA (data not 
shown). When the 400-bp &a11 fragment was used to probe TOR DNA, a strong 
hybridization to the HpuII-5 fragment was seen and a much weaker signal was 
observed for the HpuII-3 fragment. The HpuII-3/HpuII-5 fragment junction lies 
very near or at the viral origin of DNA replication. The HpuII-3 fragment is on 
the late side of the origin and the HpuII-5 fragment lies on the early side (Tooze, 
1980). These results suggest that the BgfI 500-bp repeated element in the mutant 
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FIG. 1. Viral DNA origin of the repeat element present in TT340 mutant polyoma DNA. Wild-type 
TOR polyoma DNA was digested with HpaII, separated on a 2% agarose gel, and transferred to a 
nitrocellulose filter. Filters were hybridized with 3zP-labeled Cl14 plasmid DNA (A), the Bgfi 500-bp 
repeat fragment (B) on the HpnII (C) fragment. The HpaII-3 and HpaII-5 fragments are denoted on 
the right. Filters used for the &$I-500 and the HpaII-400 hybridizations were previously probed with 
C114. The probe was removed by heating the filters to 95°C in 0.1 x SSC, 0.1% SDS and then cooled 
to room temperature; most of the counts were washed off. (D) Diagram of the region surrounding the 
origin of replication, including restriction fragments HpaII-3 and HpaII-5, HhaI-1 and HhuI-2, and 
PvuII-1, PvuII-2, and PvuII-4. 
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TT340 DNA may consist of 400 bp from the early side of the viral origin of DNA 
replication, most of which are in the HpaII 400-bp fragment, and 100 bp from the 
late side. 
Function of Insert 
Since maintenance of the additional 2500-bp insert may play a role in the mu- 
tant’s ability to replicate in embryonal carcinoma cells, the insert was removed 
and the resulting virus was assayed for ability to replicate on F9 cells. Cloned 
TT340 DNA was excised from the plasmid and used to transfect F9 cells. The 
viral DNA was extracted 4 weeks posttransfection when the cells were ex- 
pressing T antigen at a level of 30-40%. This DNA was then cleaved with Bgfl to 
excise the 500-bp repeats, gel purified, and used to transfect F9, MEF, and 3T6 
cells. By 6 weeks, the 3T6 and MEF cells had undergone a complete lytic infec- 
tion whereas the F9 cells remained negative. Subsequent infection of F9 cells 
with supernatants from transfected 3T6 and MEF cells did not result in the ex- 
pression of virus. This indicates that the 500-bp repeat was required for the ex- 
pression of TT340 cells but that removal of the insert does not impair the viability 
of the virus in cells other than EC cells. 
A further series of experiments demonstrated that insertion of the 500-bp se- 
quence into wild-type TOR conveyed the ability of this virus to replicate in F9 
cells. The fragments were purified on a 1% agarose gel and ligated to TOR DNA 
cleaved at the BglI site. The ligation mixture was used to transfect F9 and 3T6 
cells. Within 3 weeks, the 3T6 cells were 100% T antigen-positive and the F9 cells 
were 15-20% T antigen-positive. As seen in Fig. 2, the viral DNA extracted from 
the F9 cells did contain the 500-bp repeats although less than five copies were 
inserted. The linearized virus migrated just below TT340 and lost some se- 
quences, possibly of the live repeats. This is supported by the Bgfi digestion, 
which generated one fragment migrating like wt PY and a second fragment at 500 
bp, indicating that no sequence had been lost within the wild-type virus. The 
HpaII cleavage pattern was similar to TT340, which further substantiates this 
conclusion. 
Morphology and Tumorigenicity 
The mutant particles photographed and measured were similar to the wild-type 
PY and SV40 viruses. Figure 3 shows representatives of the various viruses mea- 
sured that demonstrate approximately a 5- 10% variation in size. 
Tumors appeared in 8/8 animals injected with TT340 and half the animals had 
palpable tumors 1 month following inoculation. The wild-type polyoma induced 
tumors in 6/6 animals but were palpable at 2 months postinoculation. All tumors, 
mutant and wild-type, were encapsulated, undifferentiated fibrosarcomas with no 
evidence of invasion or metastasis. Morphologically, the tumors were indistin- 
guishable. Serum obtained from the autopsied animals had antibodies to polyoma 
T antigen but no V antibodies were detected. Cell cultures were initiated from the 
tumors (Defendi and Lehman, 1966) and all grew with the phenotype of trans- 
formed cells. These tumor-derived cells were producing the polyoma T antigen 
but not the V antigen. DNA, isolated from three lines induced by the mutant 
virus, when assayed by Southern analysis demonstrated mutant DNA (data not 
shown). One of the 10 newborns injected with mutant polyoma DNA developed a 
tumor similar in morphology to those described above. 
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FIG. 2. Enzyme cleavage patterns of wild-type PY with the inserted BglI 500-pb insert. The con- 
structed virus was isolated from a F9 cell, in which it was replicating, and was cut with BnmHI (lane 
3), Bg/(lane 6), and HpaII (lane 4). Lanes 2 and 5 contain Cl14 and lane 6 contains Py6 DNA for 
comparison. The fragments were separated in a 1% agarose gel, transferred, and hybridized to a Cl14 
probe. 
DISCUSSION 
The observation that embryonal carcinoma cells are refractory to infection with 
SV40 and polyoma virus has provided an opportunity to characterize those 
events and factors which may play a role in viral expression in a mammalian cell. 
Identification and characterization of these factors may be useful in proposing 
mechanisms for cellular gene expression and differentiation. 
The mutant discussed in this paper is of interest since it contains a 2500-bp 
insert on the early noncoding side of the viral genome, which can be cut by Bgfl, 
HpaII, and HueI restriction enzymes resulting in a single band migrating at 
400-500 bp. Such fragments are present at greater than equivalent concentrations 
and appear to represent separate units. When the BglI 500-bp repeat unit was 
hybridized to wild-type polyoma, homology was seen to sequences in the virus 
DNA which included both the early and late sides of the origin of replication. 
Hybridization of the 400-bp NpaII repeat fragments to TOR DNA indicated ho- 
mology to the early region of the wild-type genome and little homology to the late 
side. The repeating unit composing the 2500-bp insertion may contain approxi- 
mately 400 bp derived from the early side of the viral genome and 100 bp from the 
late side. Each unit would be repeated approximately five times. 
To characterize whether the insertion was necessary for viral replication in F9 
cells, this fragment was excised. This virus was no longer able to infect F9 cells, 
however, 3T6 cells replicated the virus. In another series of experiments, dif- 
ferent copy numbers of the Bgn 500-bp fragment from TT340 were inserted into 
the Bgn sites of wt polyoma. When transfected onto F9 and 3T6 cells, this virus 
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FIG. 3. All three virus pools were prepared as described under Materials and Methods and photo- 
graphed. (A) Wild-type (TOR) polyoma, (B) mutant polyoma (‘lT340), and (C) wild-type SV40. 
produced T antigen within 1 week in both cells. Further, the virus recovered from 
the F9 cells migrated just below the TT340 virus demonstrating that the 500-bp 
repeat was present but in fewer copies than the original TT340 virus. These re- 
sults suggest that the insert, or a portion of it, is necessary for infection and 
replication in F9 cells. 
When the morphology of the virions was examined, the mutant virus had a 
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morphology similar to the wt virus. This is one of the few embryonal carcinoma 
mutant viruses that have been tested for tumorigenicity and the results showed an 
enhanced tumor-forming capability when the virions were utilized; however, the 
tumors were similar to tumors induced by wt virus. It is also interesting to note 
that mutant DNA resulted in a tumor in one animal. Further, when the tumor cells 
were characterized, they exhibited morphological characteristics of transformed 
cells and the presence of viral antigens and T antigen. When probed for mutant 
sequences, the tumor lines contained the mutant DNA. 
This mutant, TT340, may be different than the other mutants which have been 
described to replicate in various embryonal carcinoma cell lines. A number of 
models have been put forward suggesting a possible mechanism for replication of 
the various mutants in the embryonal carcinoma cells. These include (1) splicing 
(Sekikawa and Levine, 1981), (2) factors which stabilize the secondary structure 
of the late region making it inaccessible to RNA polymerase II, may be altered by 
a length of AT inserts which may interfere with this factor binding (Vasseur et al., 
1982), and (3) modifications in the enhancer region, for which there is evidence 
(Herbomel ef al., 1984). In fact, evidence suggests that most mutants have 
changes in the noncoding region on the late side of the origin which contains the 
enhancer. Possibly cellular factors recognize the mutated enhancer but are unable 
to recognize the wt enhancer until the cells differentiate. Recent evidence has 
suggested that the PY enhancer is not active in F9 cells but is active in differen- 
tiated cells (Linney and Donerly, 1983; Herbomel et al., 1984). However, the 
SV40 enhancer is active in both differentiated and undifferentiated cells (Sas- 
sone-Corsi et al., 1985). Possibly there are positive and negative factors which 
interact with the viral enhancers to allow the function of this region (Hen et al. 
1986). Further, these factors may be involved in cellular differentiation. 
The mutant discussed in this paper is interesting since it contains five repeats 
overlapping the origin of replication, mostly on the early side but also some se- 
quences on the late side. Contained within the insert are five extra copies of the 
origin of replication, promoter sequences for T antigen binding and transcription, 
and, possibly, the enhancer region on the late side of the origin. The further char- 
acterization of the TT340 mutant may give some further insight into the blocking 
of polyoma replication in embryonal carcinoma cells. In addition, this informa- 
tion may be useful in defining how the cell regulates gene expression and differ- 
entiation. 
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